CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene test could make leukemia treatment safer for kids
Disease control Not yet recruitingThis study aims to see if using a child's genetic information to decide the dose of a chemotherapy drug (6-MP) can reduce dangerous side effects like low white blood cell counts and infections. About 110 children with acute lymphoblastic leukemia will receive a personalized dose …
Matched conditions: CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: NA • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC
-
Leukemia drug timing under the microscope: new study aims to improve dosing
Knowledge-focused Not yet recruitingThis study looks at how long the drug calaspargase pegol stays at effective levels in the blood of children and young adults with acute lymphoblastic leukemia or lymphoma. Researchers will measure drug activity and check for links to side effects. The goal is to better understand…
Matched conditions: CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:49 UTC